TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation

Vanessa Mühlgrabner(Medical University of Vienna), Johannes B. Huppa(Howard Hughes Medical Institute), Vasco Dos Reis Gonçalves(Universitätsklinikum Würzburg), Omer Dushek(University of Oxford), Manfred Lehner(Christian Doppler Laboratory for Thermoelectricity), Benjamin Salzer(Christian Doppler Laboratory for Thermoelectricity), Wolfgang W. Schamel(Max Planck Institute of Immunobiology and Epigenetics), Dirk H. Busch(German Center for Infection Research), Iago Doel Perez(Medical University of Vienna), Angelika Plach(Medical University of Vienna), Janett Göhring(Medical University of Vienna), Hannes Stockinger(Medical University of Vienna), Susana Minguet(University of Freiburg), Michael Hudecek(Lighthouse Guild), Rubí M.-H. Velasco Cárdenas(University of Freiburg), Maria Höhrhan(Medical University of Vienna), Timo Peters(Medical University of Vienna), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jesús Siller Farfán(University of Oxford), René Platzer(Medical University of Vienna)
Science Advances
September 4, 2024
Cited by 3


Related Papers